Q&A: What does science say about plants as medicine?
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDTHCSafetyDosingHempPolicy Why This Matters Clinicians need evidence-based guidance on cannabinoid pharmacology…
#education | Sandra Milena Carrillo Gomez MD MHSM Med. Cannabis Specialist
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchIndustryPolicySafetyNeurologyMental HealthDosing Clinical Summary # Clinical Summary This article summarizes key…
#education | Sandra Milena Carrillo Gomez MD MHSM Med. Cannabis Specialist
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchPolicyIndustryNeurologyMental HealthSafetyDosing Clinical Summary # Clinical Summary This article reports on…
Medical Cannabis Linked to Improvements in Pain, Sleep and Nighttime Urination in …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. SleepPainResearchNeurologySafetyDosingAging Why This Matters I need the complete article title and summary to provide an…
Ananda Pharma Confirms Safety of MRX1 CBD Drug, as Clinical Pain Trials Approach
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CBDSafetyPainResearchDosingMental HealthAnxiety Why This Matters As CBD-based pharmaceuticals advance through clinical…
What Are Terpenes in Cannabis?
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchSafetyTHCCBDHempIndustryDosing Why This Matters Clinicians should understand that terpenes are the aromatic…
EndoDNA Launches BIOS, Turning Genetic Data Into Living Clinical Intelligence for …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDTHCAgingSafetyIndustryDosing Clinical Summary EndoDNA’s BIOS platform represents an emerging approach to…
Exilby: Europe’s First Standardized Cannabis Medicine Approved
Exilby marks a milestone as the first standardized cannabis medicine Europe has approved. This pharmaceutical-grade product offers consistent THC dosing unlike unregulated cannabis. Clinicians can now consider Exilby for safer, predictable therapeutic…
Pleopharma To Present New Data on Cannabis Withdrawal in Patients With …
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchMental HealthSafetyTHCAnxietyDosingNeurology Why This Matters Clinicians treating cannabis use disorder need…
Cannabis branding may appeal to youth despite regulations, study finds – EurekAlert!
✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchSafetyIndustryPediatricsMental HealthDosing Why This Matters Clinicians should understand that cannabis…